Abstract: A conversation system according to the invention includes: a network; a server apparatus which transfers a conversation based on characters through the network; plural terminal apparatuses which perform the conversation based on the characters under the transfer by the server apparatus through the network; and a translating apparatus which is connected to the network, receives a conversation that is transmitted from one of the plural terminal apparatuses through the network and based on characters of one language, translates the received conversation based on the characters of one language into a conversation based on characters of another language, and transmits the translated conversation based on the characters of another language to the server apparatus. The server apparatus transfers the conversation that is received from the translating apparatus and based on the characters of another language to at least one terminal apparatus during a conversation among the plural terminal apparatuses.

Abstract: The present invention provides an apparatus and method for natural language processing capable of providing an appropriate result of natural language processing. More specifically, the present invention provides a natural language processing apparatus for achieving a syntax analysis and/or a syntax generation by using natural language patterns with, at least, pattern name and pattern component. The natural language processing apparatus comprises dictionary reference means for picking up one or more natural language patterns applicable for the syntax analysis and/or the syntax generation among the natural language patterns prepared in a pattern dictionary in advance, pattern inspection means for inspecting whether the applicable natural language patterns meet a tree structure or not, and pattern application means for applying the natural language patterns to the tree structure if the natural language patterns meet the tree structure.

Abstract: Pyridine compounds of general formula: wherein —R1 represents in which R11 is hydrogen, C1-6 alkyl, halogen, hydroxy, C1-12 alkoxy, nitro, amino, C1-6 alkylsulfonylamino, C1-6 alkoxycarbonyl, C1-6 alkylamino, di (C1-6 alkyl)amino, C1-6 alkanoylamino, phenyl C1-6 alkylamino, phenylsulfonylamino, or —O—(CH2)n—R111; R2 represents hydrogen or halogen; R3 represents 1.2.3.6-tetrahydro-pyridine, or —CR31R32R33 wherein R31 represents H or C1-6 alkyl and R32 and R33 are joined to form a 5-8 membered saturated ring optionally containing up to three heteroatoms; R4 is carbamoyl, CN, carboxyl, etc.; R5 is amino, C1-6 alkylamino, di C1-6 alkylamino, etc. or salt thereof. The compound has an excellent anti-inflammatory activity, and other biological activity.

Abstract: An optically active (?)-7-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-5-[(3S)-3-piperidinyl]-1,4-dihydro-2H-pyrido[2,3-d][1,3]?-azin-2-one of the formula (I) or salt thereof. The compound has an excellent anti-inflammatory activity, and other biological activity.

Abstract: Given a source text, a desired translation of the source text into a target language, and a machine-readable dictionary, a first set of morphemes in the target language is generated from the source text, typically by using the dictionary to perform a machine translation of the source text. The second text is analyzed into a second set of morphemes in the target language. Differences between the first and second sets of morphemes are found, and morphemes corresponding to the differences are taken from the source text. Existing information including these source-text morphemes is extracted from the dictionary, and new information to be added to the dictionary is automatically generated from the extracted information and the differences. This process generates comparatively short dictionary entries, corresponding only to the differences between the two set of morphemes, and therefore creates useful dictionary entries while saving dictionary space.

Abstract: The present invention relates to a sulfonamide derivative which is useful as an active ingredient of pharmaceutical preparations. The sulfonamide derivatives of the present invention have CCR3 (CC type chemokine receptor) antagonistic activity, and can be used for the prophylaxis and treatment of diseases associated with CCR3 activity, in particular for the treatment of asthma, atopic dermatitis, allergic rhinitis and other inflammatory/immunological disorders.

Abstract: The relationship between documents is detected in consideration of the texts of the documents. A document relationship inspection apparatus which inspects the relationship between constituent elements of a first document and constituent elements of a second document, includes a logical structure parsing section which parses a logical structure of a sentence block including at least one sentence in the constituent elements of the first document and which parses a logical structure of a sentence block including at least one sentence in the constituent elements of the second document, and a relationship detection section which detects the relationship between the sentence block of the first document and the sentence block of the second document on the basis of a parsing result from the logical structure parsing section.

Abstract: 4-aryl pyrimidine compounds of general formula and salts thereof: wherein X is CH or N; R1 is hydrogen, halogen, C1-6 alkyl, C1-6 alkoxy, etc.; R2 is hydrogen or hydroxy; R3 is hydrogen, C1-6 alkyl, etc.; R4 is hydrogen, hydroxy, halogen, amino, etc.; R5 is hydroxy, amino, carboxy, etc.; R6 is hydrogen, carbamoyl, cyano, carboxy, C1-6 alkoxycarbonyl, etc. and R7 is amino or C1-6 alkanoylamino. The compounds (I) or the salts thereof have an excellent anti-inflammatory activity and the like.

Abstract: Pyridine compounds of general formula: wherein —R1 represents in which R11 is hydrogen, C1-6 alkyl, halogen, hydroxy, C1-12 alkoxy, nitro, amino, C1-6 alkylsulfonylamino, C1-6 alkoxycarbonyl, C1-6 alkylamino, di(C1-6 alkyl)amino, C1-6 alkanoylamino, phenyl C1-6 alkylamino, phenylsulfonylamino, or —O—(CH2)n—R111; R2 represents hydrogen or halogen; R3 represents hydrogen, —CR31R32R33, or —NR34R35; R4 is hydrogen, carbamoyl, CN, carboxyl, etc.; R5 is amino, C1-6 alkylamino, di C1-6 alkylamino, etc. or salt thereof. The compound has an excellent anti-inflammatory activity, and other biological activity.

Abstract: Given a source text, a desired translation of the source text into a target language, and a machine-readable dictionary, a first set of morphemes in the target language is generated from the source text, typically by using the dictionary to perform a machine translation of the source text. The second text is analyzed into a second set of morphemes in the target language. Differences between the first and second sets of morphemes are found, and morphemes corresponding to the differences are taken from the source text. Existing information including these source-text morphemes is extracted from the dictionary, and new information to be added to the dictionary is automatically generated from the extracted information and the differences. This process generates comparatively short dictionary entries, corresponding only to the differences between the two set of morphemes, and therefore creates useful dictionary entries while saving dictionary space.

Abstract: A conversation system according to the invention includes: a network; a server apparatus which transfers a conversation based on characters through the network; plural terminal apparatuses which perform the conversation based on the characters under the transfer by the server apparatus through the network; and a translating apparatus which is connected to the network, receives a conversation that is transmitted from one of the plural terminal apparatuses through the network and based on characters of one language, translates the received conversation based on the characters of one language into a conversation based on characters of another language, and transmits the translated conversation based on the characters of another language to the server apparatus. The server apparatus transfers the conversation that is received from the translating apparatus and based on the characters of another language to at least one terminal apparatus during a conversation among the plural terminal apparatuses.

Abstract: The present invention provides an apparatus and method for natural language processing capable of providing an appropriate result of natural language processing. More specifically, the present invention provides a natural language processing apparatus for achieving a syntax analysis and/or a syntax generation by using natural language patterns with, at least, pattern name and pattern component. The natural language processing apparatus comprises dictionary reference means for picking up one or more natural language patterns applicable for the syntax analysis and/or the syntax generation among the natural language patterns prepared in a pattern dictionary in advance, pattern inspection means for inspecting whether the applicable natural language patterns meet a tree structure or not, and pattern application means for applying the natural language patterns to the tree structure if the natural language patterns meet the tree structure.

Abstract: A document retrieval and display system for retrieving source documents in different languages from servers linked by a communication network, translating the retrieved source documents as necessary, storing the translated documents, and displaying the source documents and translated documents at a client device connected to the communication network. The translation process is activated automatically by a control module, and is carried out by a machine translation module. The control module decides when a translation is necessary, selects whether to display the source document or a translated document at the client device, and determines when the source document has been updated and must be retranslated.

Abstract: The present invention provides novel compounds represented by the general formula I: ##STR1## wherein R.sub.1 is a straight or branched lower alkyl, a cycloalkyl-lower alkyl, an aryl-lower alkyl, a cycloalkyl, an aryl an aryl-cycloalkyl, lower alkoxy, an aryloxy, or a heteroaryl;R.sub.2 is hydrogen, a straight or branched lower alkyl, a cycloalkyl, or a cycloalkyl-lower alkyl;R.sub.3 and R.sub.3 ' are each the same or different and each is hydrogen atom, a straight or branched lower alkyl, a cycloalkyl, an aryl-lower alkyl, an aryl, or a heteroaryl; orR.sub.3 and R.sub.3 ' together form a ring structure;R.sub.3 " is hydrogen, lower alkyl or an aryl; orR.sub.2 and R.sub.3 " together form a lower alkylene group --(CH.sub.2).sub.n -- wherein n is an integer of 1, 2 or 3; orR.sub.2 and R.sub.3 " together form a group represented by the formula: --(CH.sub.2).sub.p --Ar-- or --Ar--(CH.sub.2).sub.p --, respectively, wherein p is zero or an integer of 1 or 2, and Ar is an arylene or heteroarylene;C(.dbd.X) is C(.dbd.

Abstract: The present invention provides novel compounds having pharmacological properties represented by the general formula I ##STR1## processes for the manufacture, pharmaceutical compositions and the use of the compounds of formula I and salts thereof.